These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18089816)

  • 1. A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
    Shu ST; Nadella MV; Dirksen WP; Fernandez SA; Thudi NK; Werbeck JL; Lairmore MD; Rosol TJ
    Cancer Res; 2007 Dec; 67(24):11859-66. PubMed ID: 18089816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NF-kappaB in adult T-cell leukemia/lymphoma.
    Nadella MV; Dirksen WP; Nadella KS; Shu S; Cheng AS; Morgenstern JA; Richard V; Fernandez SA; Huang TH; Guttridge D; Rosol TJ
    Leukemia; 2007 Aug; 21(8):1752-62. PubMed ID: 17554373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteolytic bone resorption in adult T-cell leukemia/lymphoma.
    Shu ST; Martin CK; Thudi NK; Dirksen WP; Rosol TJ
    Leuk Lymphoma; 2010 Apr; 51(4):702-14. PubMed ID: 20214446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation.
    Nadella MV; Shu ST; Dirksen WP; Thudi NK; Nadella KS; Fernandez SA; Lairmore MD; Green PL; Rosol TJ
    Retrovirology; 2008 Jun; 5():46. PubMed ID: 18541021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
    Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
    Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
    Ishikawa C; Senba M; Mori N
    Invest New Drugs; 2021 Apr; 39(2):317-329. PubMed ID: 32959166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.
    Nadella MV; Kisseberth WC; Nadella KS; Thudi NK; Thamm DH; McNiel EA; Yilmaz A; Boris-Lawrie K; Rosol TJ
    Vet Comp Oncol; 2008 Mar; 6(1):39-54. PubMed ID: 19178662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.
    Satou Y; Nosaka K; Koya Y; Yasunaga JI; Toyokuni S; Matsuoka M
    Leukemia; 2004 Aug; 18(8):1357-63. PubMed ID: 15190257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
    PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro.
    Shu ST; Dirksen WP; Lanigan LG; Martin CK; Thudi NK; Werbeck JL; Fernandez SA; Hildreth BE; Rosol TJ
    Leuk Lymphoma; 2012 Apr; 53(4):688-98. PubMed ID: 21942940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.
    Banerjee P; Tripp A; Lairmore MD; Crawford L; Sieburg M; Ramos JC; Harrington W; Beilke MA; Feuer G
    Blood; 2010 Apr; 115(13):2640-8. PubMed ID: 20124219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma.
    Richard V; Nadella MV; Green PL; Lairmore MD; Feuer G; Foley JG; Rosol TJ
    Leukemia; 2005 Jul; 19(7):1175-83. PubMed ID: 15889157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
    Nasr R; El-Sabban ME; Karam JA; Dbaibo G; Kfoury Y; Arnulf B; Lepelletier Y; Bex F; de Thé H; Hermine O; Bazarbachi A
    Oncogene; 2005 Jan; 24(3):419-30. PubMed ID: 15543232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia.
    Tan C; Waldmann TA
    Cancer Res; 2002 Feb; 62(4):1083-6. PubMed ID: 11861386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants.
    Mitra-Kaushik S; Harding JC; Hess JL; Ratner L
    Blood; 2004 Aug; 104(3):802-9. PubMed ID: 15090453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of parathyroid hormone-like activity from human T-cell lymphotropic virus type I-infected lymphocytes.
    Fukumoto S; Matsumoto T; Watanabe T; Takahashi H; Miyoshi I; Ogata E
    Cancer Res; 1989 Jul; 49(14):3849-52. PubMed ID: 2544261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.
    Rauch DA; Olson SL; Harding JC; Sundaramoorthi H; Kim Y; Zhou T; MacLeod AR; Challen G; Ratner L
    Retrovirology; 2020 Aug; 17(1):27. PubMed ID: 32859220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
    Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
    Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.